Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.

Front Oncol · 2022 · PMC9484462 · PMID 36132153

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

Otherwise, effects on QALYs were marginally significant across scenarios evaluated [positive in all but the complete case analysis (scenario 16)] and fairly closely clustered around the main result.

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.